MaxCyte to Participate in Two Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Oct 31, 2024
ROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced Company management will participate at two upcoming investor conferences.
Read more at globenewswire.com
